Extendicare Inc. (TSE:EXE – Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as C$23.22 and last traded at C$22.89, with a volume of 72764 shares. The stock had previously closed at C$22.75.
Analysts Set New Price Targets
EXE has been the subject of several research analyst reports. Royal Bank Of Canada upgraded shares of Extendicare from a “hold” rating to a “moderate buy” rating and lifted their target price for the company from C$15.00 to C$25.00 in a research report on Thursday, December 4th. TD Securities lifted their price objective on shares of Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Natl Bk Canada raised Extendicare to a “strong-buy” rating in a research note on Wednesday, December 3rd. Cormark raised their price target on Extendicare from C$25.00 to C$30.00 in a research report on Wednesday, December 3rd. Finally, CIBC lifted their price target on Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. Three equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, Extendicare currently has an average rating of “Buy” and an average price target of C$23.86.
Get Our Latest Stock Report on Extendicare
Extendicare Stock Down 0.3%
Extendicare Announces Dividend
The business also recently declared a monthly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 17th were given a $0.042 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Friday, October 31st. Extendicare’s payout ratio is currently 46.60%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
